388 related articles for article (PubMed ID: 28135635)
1. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
Lütjens R; Rocher JP
Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
[TBL] [Abstract][Full Text] [Related]
2. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
3. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
Feng Z; Hu G; Ma S; Xie XQ
AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
[TBL] [Abstract][Full Text] [Related]
4. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
Christopher JA; Doré AS; Tehan BG
Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Persechino M; Hedderich JB; Kolb P; Hilger D
Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
[TBL] [Abstract][Full Text] [Related]
6. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulators of G-protein-coupled receptors.
May LT; Christopoulos A
Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
[TBL] [Abstract][Full Text] [Related]
8. Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.
Conn PJ; Lindsley CW; Meiler J; Niswender CM
Nat Rev Drug Discov; 2014 Sep; 13(9):692-708. PubMed ID: 25176435
[TBL] [Abstract][Full Text] [Related]
9. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
10. Current and Future Challenges in GPCR Drug Discovery.
Topiol S
Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
[TBL] [Abstract][Full Text] [Related]
11. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
Hurevich M; Talhami A; Shalev DE; Gilon C
Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modulation of G protein-coupled receptors.
May LT; Avlani VA; Sexton PM; Christopoulos A
Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
Müller CE; Schiedel AC; Baqi Y
Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation of G protein-coupled receptors.
May LT; Leach K; Sexton PM; Christopoulos A
Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
[TBL] [Abstract][Full Text] [Related]
15. Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery.
Wang Y; Yu Z; Xiao W; Lu S; Zhang J
Drug Discov Today; 2021 Mar; 26(3):690-703. PubMed ID: 33301977
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
18. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.
Bian Y; Jun JJ; Cuyler J; Xie XQ
Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870
[TBL] [Abstract][Full Text] [Related]
19. Trends in GPCR drug discovery: new agents, targets and indications.
Hauser AS; Attwood MM; Rask-Andersen M; Schiöth HB; Gloriam DE
Nat Rev Drug Discov; 2017 Dec; 16(12):829-842. PubMed ID: 29075003
[TBL] [Abstract][Full Text] [Related]
20. The use of conformationally thermostabilised GPCRs in drug discovery: application to fragment, structure and biophysical techniques.
Tehan BG; Christopher JA
Curr Opin Pharmacol; 2016 Oct; 30():8-13. PubMed ID: 27400445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]